Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study

被引：0
|
作者：
Rachelle Buchbinder
Sharon Van Doornum
Margaret Staples
Marissa Lassere
Lyn March
机构：
[1] School of Public Health and Preventive Medicine,Department of Epidemiology and Preventive Medicine
[2] Monash University,Monash Department of Clinical Epidemiology
[3] Cabrini Institute,Department of Medicine (Royal Melbourne Hospital)
[4] The University of Melbourne,St George Hospital
[5] University of New South Wales,Florance and Cope Professorial Department of Rheumatology
[6] Royal North Shore Hospital,undefined
[7] Institute of Bone and Joint Research,undefined
[8] University of Sydney ,undefined
来源：
BMC Musculoskeletal Disorders | / 16卷
关键词：
Rheumatoid arthritis; Malignancy; Tumour necrosis factor; Biologic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Buchbinder, Rachelle
    Van Doornum, Sharon
    Staples, Margaret
    Lassere, Marissa
    March, Lyn
    BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [2] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Margaret P. Staples
    Lyn March
    Catherine Hill
    Marissa Lassere
    Rachelle Buchbinder
    BMC Rheumatology, 3
  • [3] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Staples, Margaret P.
    March, Lyn
    Hill, Catherine
    Lassere, Marissa
    Buchbinder, Rachelle
    BMC RHEUMATOLOGY, 2019, 3 (01)
  • [4] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [5] Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database
    Staples, Margaret P.
    March, Lyn
    Lassere, Marissa
    Reid, Chris
    Buchbinder, Rachelle
    RHEUMATOLOGY, 2011, 50 (01) : 166 - 175
  • [6] Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Mercer, Louise K.
    Lunt, Mark
    Low, Audrey L. S.
    Dixon, William G.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1087 - 1093
  • [7] Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
    van Dartel, Sanne A. A.
    Fransen, Jaap
    Kievit, Wietske
    Dutmer, Ellen A. J.
    Brus, Herman L. M.
    Houtman, Nella M.
    van de Laar, Mart A. F.
    van Riel, Piet L. C. M.
    RHEUMATOLOGY, 2013, 52 (06) : 1052 - 1057
  • [8] Experiences and needs for work participation in employees with rheumatoid arthritis treated with anti-tumour necrosis factor therapy
    Van der Meer, Marrit
    Hoving, Jan L.
    Vermeulen, Marjolein I. M.
    Herenius, Marieke M. J.
    Tak, Paul P.
    Sluiter, Judith K.
    Frings-dresen, Monique H. W.
    DISABILITY AND REHABILITATION, 2011, 33 (25-26) : 2587 - 2595
  • [9] Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis
    Jung, Seung Min
    Kim, Hyun-Sook
    Kim, Hae-Rim
    Kim, Na Young
    Lee, Jung-Hwa
    Kim, Juryun
    Kwok, Seung-Ki
    Park, Kyung-Su
    Park, Sung-Hwan
    Kim, Ho-Youn
    Ju, Ji Hyeon
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (01) : 20 - 25
  • [10] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Roux, C. H.
    Brocq, O.
    Breuil, V.
    Albert, C.
    Euller-Ziegler, L.
    RHEUMATOLOGY, 2007, 46 (04) : 695 - 698
12345